Effect of different caloric loads in human jejunum on meal-stimulated and nonstimulated biliopancreatic secretion.

Am J Clin Nutr

Unité de Recherches sur la Physiopathologie de la Digestion (INSERM U54), Hôpital Saint Lazare, Paris, France.

Published: March 1988

The effects on biliopancreatic secretion of two caloric loads (1.3 and 3.3 kcal/min of Realmentyl: proteins 18%, lipids 27%, carbohydrates 55%), infused into the jejuna of 10 healthy men, were compared with those of a control solution. In one set of experiments (six subjects) when biliopancreatic secretion was not stimulated before infusion, the rate 1.3 kcal/min resulted in mild stimulation whereas the rate 3.3 kcal/min brought about an inhibition of biliopancreatic secretion. In another set of experiments (six subjects) when biliopancreatic secretion was stimulated by ingestion of an homogenized meal (400 mL, 490 kcal) 1 h before the start of infusion, both loads resulted in strong inhibition of pancreatic secretions, the effect being more pronounced with the high caloric load.

Download full-text PDF

Source
http://dx.doi.org/10.1093/ajcn/47.3.400DOI Listing

Publication Analysis

Top Keywords

biliopancreatic secretion
20
caloric loads
8
set experiments
8
experiments subjects
8
subjects biliopancreatic
8
secretion stimulated
8
rate kcal/min
8
biliopancreatic
5
secretion
5
loads human
4

Similar Publications

[Small intestine bacterial overgrowth: Myths and realities].

Aten Primaria

January 2025

Medicina Familiar y Comunitaria, Centro de Salud Los Ángeles, Madrid; Grupo de trabajo de Patología digestiva y hepática de la semFYC; Grupo de trabajo de Digestivo de la SoMaMFyC, España.

The small intestine bacterial overgrowth (SIBO) is a clinical disorder resulting from colonization of the small intestine by an excessive number of microorganisms or by unusual microorganisms. When they are methane producers it is called intestinal methanogen overgroth (IMO). Known risk factors are congenital or acquired anatomical alterations, motility alterations, some systemic and autoimmune diseases, those that cause alterations in biliopancreatic secretions, hypochlorhydria and some drugs.

View Article and Find Full Text PDF

To investigate the mechanism of pancreatic alveolar cell autophagy in rats with severe acute pancreatitis (SAP) by phillygenin (PHI) based on the PI3K/Akt/mToR pathway. Rats were randomly divided into control group (CON group), SAP model group (SAP group) and PHI treatment group (SAP+PHI group), with 10 rats in each group. 5% sodium taurocholate was injected retrogradely into the biliopancreatic duct to establish a SAP rat model, and PHI was injected intraperitoneally into the pancreas after successful establishment of the model.

View Article and Find Full Text PDF

Bariatric and endo-bariatric interventions for diabetes: What is the current evidence?

World J Diabetes

November 2024

Department of Endocrinology and Metabolism, Lancashire Teaching Hospitals NHS Trust, Preston PR2 9HT, Lancashire, United Kingdom.

Bariatric interventions have shown the best therapeutic benefits in individuals with obesity. They can be classified into surgical procedures (bariatric/metabolic surgery) and endoscopic procedures. Common surgical procedures include sleeve gastrectomy, Roux-en-Y gastric bypass, bilio-pancreatic diversion with or without duodenal switch and Stomach Intestinal Pylorus Sparing Surgery.

View Article and Find Full Text PDF
Article Synopsis
  • The study explores different surgical configurations of Roux-en-Y gastric bypass (RYGB) using obese mice, comparing a standard version (RYGB S) and a variant with a longer biliopancreatic limb (RYGB L).
  • RYGB S resulted in a higher survival rate (67%) compared to RYGB L (40%), which showed significant weight loss but also adverse health effects like reduced heart mass and unexplained deaths.
  • Both surgical groups had lower fat mass and bone density compared to lean controls, while the gut microbiota showed minimal differences aside from a lower abundance of Eubacterium in the longer BPL group.
View Article and Find Full Text PDF

Comparison of clinical characteristics and prognostic factors in two site-specific categories of ampullary cancer.

World J Gastroenterol

October 2024

Department of Biliopancreatic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, Hubei Province, China.

Article Synopsis
  • Ampullary cancer is a rare but increasingly diagnosed malignant tumor with unclear biological characteristics, especially concerning its different subtypes and the effectiveness of adjuvant therapy.
  • A study examined 356 patients to analyze clinicopathological features between two subtypes: ampulla of Vater cancer (AVC) and duodenal papilla cancer (DPC), measuring factors that influence overall survival (OS).
  • Results revealed that DPC patients had a longer OS (58.90 months) than AVC patients (44.31 months), with different independent risk factors affecting survival for each subtype, highlighting the importance of preoperative health metrics and treatment approaches.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!